Over 20 years ago, JRS PHARMA developed a new and innovative excipient, PROSOLV® SMCC (silicified microcrystalline cellulose), to alleviate some of the known deficiencies of conventional binders including: low bulk density, poor flow, loss of compatibility, stickiness issues, and sensitivity to lubricants. PROSOLV® SMCC not only addresses these challenges, but also offers enhanced performance.

PROSOLV SMCC - Click to download the Brochure

Privacy Policy

We Value Your Privacy

This website uses external tools and components to provide you the best experience on our website. You will find more detailed information in our privacy policy.